ADAM STANDIFORD: Open Payments
NPI 1932731999 · PORTAGE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,880 in 107 payments from 19 companies in 2025. Trend: 2023 $3,988 · 2024 $2,213 · 2025 $3,880
Food & beverage: $2,427Consulting: $1,440Education: $13
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 13 | $1,744 |
| ABBVIE INC. | 20 | $456 |
| Janssen Biotech, Inc. | 13 | $334 |
| UCB, Inc. | 10 | $320 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $168 |
| GENZYME CORPORATION | 6 | $150 |
| PFIZER INC. | 6 | $123 |
| Lilly USA, LLC | 5 | $122 |
| Amgen Inc. | 7 | $119 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
Products named: SKYRIZI, TREMFYA, Bimzelx, OPZELURA, DUPIXENT, ILUMYA, EUCRISA, TALTZ.
Industry payments across MI — which companies pay providers there.
